Dec 01, 2020 / 04:30PM GMT
Meta A. Marshall - Morgan Stanley, Research Division - VP
Thanks, everybody, for joining. I'm going to -- I'm Meta Marshall. I laid up the networking coverage here at Morgan Stanley. We're pleased to here -- to have Lumentum here today. We have Alan Lowe, President and CEO; Chris Coldren, SVP of Strategy & Corporate Development; and Jim Fanucchi, who works on the IR team.
I'm going to start with a brief disclosure. So for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your MS Sales representative. So let's jump in with questions.You guys have had a really phenomenal transformation over the past couple of years, moving from high 40s gross margins to -- and 20s operating margins from low 30s and single-digit operating margins pre-Oclaro acquisition.
How much of this accretion do you think was just due to acquiring the portfolio to higher margin products? Or what was kind of optimization you were able to do as a result of the Oclaro acquisition?
Lumentum Holdings Inc at Nasdaq Virtual Investor Conference Transcript
Dec 01, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers